Tissue-specific regulation of basic fibroblast growth factor mRNA levels by diabetes

Diabetes ◽  
1992 ◽  
Vol 41 (2) ◽  
pp. 222-226 ◽  
Author(s):  
C. W. Karpen ◽  
R. G. Spanheimer ◽  
A. L. Randolph ◽  
W. L. Lowe
Diabetes ◽  
1992 ◽  
Vol 41 (2) ◽  
pp. 222-226 ◽  
Author(s):  
C. W. Karpen ◽  
R. G. Spanheimer ◽  
A. L. Randolph ◽  
W. L. Lowe

Pteridines ◽  
2003 ◽  
Vol 14 (1) ◽  
pp. 9-12 ◽  
Author(s):  
Shunichi Shimizu ◽  
Yoshiyuki Miyasaka ◽  
Shinichiro Yamamoto ◽  
Masakazu Ishii ◽  
Yuji Kiuchi

Abstract The purpose of this study was to examine whether basic fibroblast growth factor (bFGF) stimulates tetrahydrobiopterin (BH4) synthesis in mouse brain microvascular endothelial cells. BH4 content was determined by oxidation under acidic conditions as biopterin and analysed with reversed-phase high Performance liquid chromatography. Measurement of the mRNA level of QTP-cyclohydrolase I (GTPCH), which is the rate-limiting enzyme of the de novo pathway of BH4 synthesis. The addition of bFGF to endothelial cells increased the BH4 content and GTPCH mRNA levels in an incubation period- and a concentration-dependent manner. 2,4-Diamino-6- hydroxypyrimidine, an inhibitor of GTPCH, strongly reduced the bFGF-induced increase in BH4 content. These findings suggest that bFGF stimulates BH4 synthesis via a de novo pathway with the induction of GTPCH.


Sign in / Sign up

Export Citation Format

Share Document